发表研究结果有使用 ab28947?请让我们知道,以便我们可以引用本数据表中的参考文章。

ab28947 被引用在 25 文献中.

  • Kigoshi Y  et al. CACUL1/CAC1 Regulates the Antioxidant Response by Stabilizing Nrf2. Sci Rep 5:12857 (2015). WB ; Human . PubMed: 26238671
  • Schäfer M  et al. Activation of Nrf2 in keratinocytes causes chloracne (MADISH)-like skin disease in mice. EMBO Mol Med 6:442-57 (2014). IHC-P ; Mouse . PubMed: 24503019
  • Gambari L  et al. Sodium hydrosulfide inhibits the differentiation of osteoclast progenitor cells via NRF2-dependent mechanism. Pharmacol Res 87:99-112 (2014). Human . PubMed: 24998607
  • Wang R  et al. Seaweed extracts and unsaturated fatty acid constituents from the green alga Ulva lactuca as activators of the cytoprotective Nrf2-ARE pathway. Free Radic Biol Med 57:141-53 (2013). PubMed: 23291594
  • Kitaoka Y  et al. Oxidative stress and Nrf2 signaling in McArdle disease. Mol Genet Metab 110:297-302 (2013). PubMed: 23906480
  • Inui T  et al. Association of p62/SQSTM1 Excess and Oral Carcinogenesis. PLoS One 8:e74398 (2013). IHC-P ; Human . PubMed: 24086340
  • Piao MS  et al. Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying and antioxidant enzymes during keratinocyte differentiation. Arch Dermatol Res 304:387-95 (2012). WB . PubMed: 22310733
  • Ghosh S  et al. Global gene expression profiling of endothelium exposed to heme reveals an organ-specific induction of cytoprotective enzymes in sickle cell disease. PLoS One 6:e18399 (2011). IHC-P ; Human . PubMed: 21483798
  • Ivanov AV  et al. Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 Cells. PLoS One 6:e24957 (2011). WB ; Human . PubMed: 21931870
  • Khutornenko AA  et al. From the Cover: Pyrimidine biosynthesis links mitochondrial respiration to the p53 pathway. Proc Natl Acad Sci U S A 107:12828-33 (2010). WB, ICC/IF ; Human . PubMed: 20566882
  • Zeller I  et al. Lead contributes to arterial intimal hyperplasia through nuclear factor erythroid 2-related factor-mediated endothelial interleukin 8 synthesis and subsequent invasion of smooth muscle cells. Arterioscler Thromb Vasc Biol 30:1733-40 (2010). WB ; Human . PubMed: 20595649
  • Yang L  et al. Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One 4:e5757 (2009). WB ; Human . PubMed: 19484125
  • Fischer AJ  et al. Differential Gene Expression in Human Conducting Airway Surface Epithelia and Submucosal Glands. Am J Respir Cell Mol Biol : (2008). PubMed: 18703793
  • Okada K  et al. Ursodeoxycholic Acid Stimulates Nrf2-Mediated Hepatocellular Transport, Detoxification and Antioxidative Stress Systems in Mice. Am J Physiol Gastrointest Liver Physiol : (2008). PubMed: 18687751
  • Cleton-Jansen AM  et al. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. BMC Cancer 8:105 (2008). PubMed: 18416817
  • Dehn DL  et al. 5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo. Mol Cancer Ther 5:1702-9 (2006). PubMed: 16891456
  • Umemura T  et al. A crucial role of Nrf2 in in vivo defense against oxidative damage by an environmental pollutant, pentachlorophenol. Toxicol Sci 90:111-9 (2006). PubMed: 16352618
  • Anwar A  et al. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem 278:10368-73 (2003). PubMed: 12529318
  • Zappa F  et al. NAD(P)H: quinone oxidoreductase 1 expression in kidney podocytes. J Histochem Cytochem 51:297-302 (2003). PubMed: 12588957
  • Winski SL  et al. Subcellular localization of NAD(P)H:quinone oxidoreductase 1 in human cancer cells. Cancer Res 62:1420-4 (2002). PubMed: 11888914
  • Siegel D  et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol 59:263-8 (2001). PubMed: 11160862
  • Siegel D  et al. NAD(P)H: quinone oxidoreductase 1 expression in human bone marrow endothelial cells. Toxicol Lett 125:93-8 (2001). PubMed: 11701227
  • Schelonka LP  et al. Immunohistochemical localization of NQO1 in epithelial dysplasia and neoplasia and in donor eyes. Invest Ophthalmol Vis Sci 41:1617-22 (2000). PubMed: 10845577
  • Moran JL  et al. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci U S A 96:8150-5 (1999). PubMed: 10393963
  • Siegel D  et al. Immunohistochemical detection of NAD(P)H:quinone oxidoreductase in human lung and lung tumors. Clin Cancer Res 4:2065-70 (1998). PubMed: 9748120

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"